FNBT
CLVS

FineMark National Bank & Trust’s Clovis Oncology, Inc. CLVS Stock Holding History

FineMark National Bank & Trust’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-13
Closed -$1K – 1070
2016
Q4 		$1K Buy
+13
New +$458 ﹤0.01% 1261

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

FineMark National Bank & Trust's CLVS Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Clovis Oncology, Inc. (CLVS) in Q1 2017, closing a stake of 13 shares — an estimated $1K sold.

FineMark National Bank & Trust first reported a position in CLVS in Q4 2016 and held it in 1 quarter. The position peaked at $1K in Q4 2016. 229 funds tracked by Wall St. Rank hold CLVS as of Q1 2017.

  • FineMark National Bank & Trust reported no remaining Clovis Oncology, Inc. position as of Q1 2017 after selling out during the quarter.
  • FineMark National Bank & Trust sold 13 Clovis Oncology, Inc. shares in Q1 2017, an estimated $1K.
  • FineMark National Bank & Trust first reported a position in Clovis Oncology, Inc. in Q4 2016 and held it in 1 quarter.
  • FineMark National Bank & Trust's Clovis Oncology, Inc. position peaked at $1K in Q4 2016.
  • 229 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.